1/14
07:36 am
neo
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
1/12
10:37 am
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
1/12
07:48 am
neo
NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]
Medium
Report
NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]
1/12
07:20 am
neo
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]
Medium
Report
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]
1/12
07:05 am
neo
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
Medium
Report
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
1/7
10:58 am
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.
1/6
02:33 pm
neo
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift [Yahoo! Finance]
Low
Report
A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift [Yahoo! Finance]
1/5
07:40 am
neo
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
07:05 am
neo
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
12/30
08:06 am
neo
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors [Yahoo! Finance]
Low
Report
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors [Yahoo! Finance]
12/30
07:05 am
neo
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
Low
Report
NeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. “Jack” Kenny to its Board of Directors
12/17
06:42 am
neo
3 Stocks Under $50 We Steer Clear Of [Yahoo! Finance]
Low
Report
3 Stocks Under $50 We Steer Clear Of [Yahoo! Finance]
12/15
07:50 am
neo
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation [Yahoo! Finance]
Low
Report
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation [Yahoo! Finance]
12/15
07:05 am
neo
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
Low
Report
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
12/10
07:42 am
neo
NeoGenomics to Present New ctDNA Research at SABCS 2025 [Yahoo! Finance]
Low
Report
NeoGenomics to Present New ctDNA Research at SABCS 2025 [Yahoo! Finance]
12/10
07:05 am
neo
NeoGenomics to Present New ctDNA Research at SABCS 2025
Low
Report
NeoGenomics to Present New ctDNA Research at SABCS 2025
12/8
08:05 am
neo
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
Low
Report
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
12/5
03:05 pm
neo
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
Low
Report
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
11/25
01:54 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
01:18 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
01:27 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
06:58 am
neo
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
Medium
Report
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
11/7
01:14 am
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
07:05 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences
Low
Report
NeoGenomics to Participate in Upcoming Investor Conferences
10/30
12:51 pm
neo
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Medium
Report
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors